
People still being denied improved treatment for multidrug-resistant TB
MSF urges governments to step up the use of newer TB drugs Guadalajara, Mexico, October 13, 2017 – People with multidrug-resistant tuberculosis (MDR-TB) are still not receiving two newer TB drugs, bedaquiline and delamanid, which have been available for more